The involvement of p53 in the formation of chromosome aberrations was assessed by analyzing bleomycin-induced, chromatid-type aberrations in G 2 phase fibroblasts derived from embryos from wild-type and p53 knock-out mice. Cells that were p53 + /-or pS3-l-were more sensitive to the induction of aberrations than the p53+/+ cells, particularly at concentrations of 7.5 and 10.0 llg/ml. The p53-deficient cells also showed an overdispersed distribution of bleomycin-induced chromatid aberrations, a greater amount of overall genomic instability and a possible loss of a cell death pathway. These data are interpreted as indicating a role for p53 in DNA repair in the G 2 phase, with a loss of p53 leading to an increased frequency of deletions (incomplete repair) and interchanges (misrepair). The specific role remains to be elucidated. The mitotk index decreased with increasing bleomycin concentration to a similar extent in all three cell lines, indicating that the loss of a G 2 checkpoint in p53-/-and p53+/-cells was not an explanation for the increased sensitivities in these cells compared with the p53+/+.
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Signals from damaged DNA can activate a p53-dependent transduction pathway, which includes G|/S and G 2 /M arrest and repair of DNA damage. In part, these functions operate through the induction of Gadd45 and p21 for G|/S arrest in transformed cell lines (1) and for G 2 /M in yeast through the MEC and Rad3 genes (2) . The cellular responses to induced DNA damage are complex and include induction of transcription, cell cycle arrest and effects on DNA replication and repair. These responses can be manifest as gene amplification, aneuploidy and the production of chromosomal aberrations and mutations (3) (4) (5) (6) (7) (8) . DNA strand breaks appear to be essential for the induction of p53 (9,10), which can bind directly to the strand break (11,12) through its C-terminal region (13, 16) . Additional strand break binding proteins are present in cells, in particular the complex of Ku and the DNA-PKcs (17, 18) . The p53 protein is a substrate for Ku, but it remains to be determined if p53 and/or Ku provide a signal for the DNA repair complex to be recruited to the damage.
The p53 protein can be activated by exogenous treatments in all stages of the cell cycle, not only in the G, phase (19) , indicating roles for p53 in addition to those proposed for the Gj/S checkpoint. It appears that one function in some cell types is to arrest cells in G 2 to allow for repair, or apoptosis, prior to mitosis (20) (21) (22) . However, this function of p53 is certainly not a universal one, especially for non-transformed cells (23) .
Evidence for a direct association of the p53 protein to DNA repair events is accumulating rapidly (8, 12, 15, (24) (25) (26) . This © Oxford University Press can provide a means by which there is a co-ordination of the cell cycle control by cyclin-dependent protein kinases and DNA repair in cells after exposure to DNA-damaging agents (27) (28) (29) (30) .
Since there is no proven function of p53 as an initiator of a G 2 checkpoint and yet its level is increased in G 2 in response to exposure to exogenous agents, we hypothesized that p53 could have a role by enhancing DNA repair. If p53-deficient cells lack this proposed p55-mediated damage recognition and normal repair, they would contain a higher frequency of unrepaired or misrepaired DNA double-strand breaks and altered bases than p53-proficient cells. The unrepaired DNA double-strand breaks would be observed as chromatid deletions at metaphase and the misrepaired ones as chromatid interchanges. To study this, p53+/+, p53+l-and p53-l-mouse embryonic fibroblast cells were treated with bleomycin, and cells harvested at a time after treatment (5 h) when it was calculated that only G 2 cells would have reached metaphase. The selection of a 5 h interval between the end of bleomycin treatment and fixation was based on the fact that the cell cycle durations for the three lines were in excess of 36 h, and G 2 is typically >20% of this. Chromosomal aberrations were analyzed in these cells and the frequencies and types compared for each genotype.
Embryonic fibroblasts from p55-deficient knock-out (p53+/-and p53-/-) and littermate wild-type (p53+/+) mice were kindly provided by Dr Tyler Jacks (Massachusetts Institute of Technology, Cambridge, MA). The cells were derived and cultured as in Livingstone et al. (31) . All cell lines were untransformed and grown as monolayers in DMEM (GIBCO/BRL, Grand Island, NY), supplemented with 10% heat-inactivated fetal calf serum (Hazleton, Denver, PA), 0.5% penicillin-streptomycin (GIBCO/BRL) and incubated at 37°C in a 5% CO 2 humidified atmosphere for 24 h. Lyophilized bleomycin (Sigma, St Louis, MO) was dissolved in serumfree DMEM at a concentration of 10 (lg/|il immediately prior to use. Two independent experiments were conducted that were identical in design with the exception of the bleomycin concentrations used. Experiment 2 included additional concentrations of bleomycin, since it was determined from experiment 1 that these would be needed to define better the concentration response curves for each cell line, and the concentration range over which differential sensitivity might be observed. In experiment 1, bleomycin was added to the exponentially growing cells (passage 4, 5 or 6) at final concentrations of 0, 5 or 10 u.g/ml in serum-free DMEM, and incubated at 37°C for 1 h. In experiment 2, bleomycin concentrations of 0, 2.5, 5, 7.5 or 10 (ig/ml were used. The cells were washed and allowed to recover in 10% DMEM for 30 min and then treated with colchicine (10~7 M) at 37°C for 4.5 h before harvest. Cells were treated with hypotonic KC1 (75 mM) for 15 min and then fixed in 3 parts anhydrous methanol/1 part glacial acetic acid, dispersed onto slides and stained with 2.5% aqueous Giemsa (Cabisco, Burlington, NC). For each treatment "One hundred cells scored for each group, at 0, 5, 10 (ig/ml; 200 for each group at 2.5 and 7.5 (ig/ml.
•"Per 100 cells at 0, 5 and 10 ng/ml; per 200 cells at 2.5 and 7.5 ug/ml. Interchanges. d Data for experiment 2. in experiment 1, 100 metaphases were analyzed for chromosome aberrations by bright-field microscopy. In experiment 2, 200 cells were analyzed for 2.5 and 7.5 (ig/ml, and 100 cells for each of the other treatment groups. The number of centromeres was recorded to permit statistical analysis on observations per chromosome, since the number of chromosomes per cell varied quite markedly for all cell lines. The mitotic index was assessed by counting 500 cells from each cell line at. each concentration of bleomycin.
Although two independent experiments were conducted, there were no significant differences in the frequencies for common exposures between the two experiments, and so the discussion here will consider the data as a single unit. For completeness, the data for chromatid aberration frequencies in the p53+/+, +/-and -/ -cell lines are shown for the two experiments separately in Table I , but combined in Figures 1  and 2 . The concentration-response curves for total chromatid aberrations per cell for the p55-deficient cells are markedly non-linear, while that for the wild-type cells is approximately linear up to 7.5 |ig/ml, with a decrease in frequency at 10 |ig/ml (Figure 1) . This plateau at the highest concentration in the p53+/+ cells could in part be due to an enhanced repair at higher levels of DNA damage or to some bleomycin-induced cytotoxicity in these cells, perhaps by an apoptosis-like pathway as discussed below. The ratios of chromatid aberration frequencies per cell for the 10 (ig/ml concentration to the untreated control were ~3.7 for p53+/+ cells, -8.7 for p53+/-cells and ~13.5 for p53-l-cells. The differences were highly significant (P <Z 0.01). There were similar clear differences between p55-deficient and wild-type cells at 7.5 H-g/ml, with less difference at the lower two concentrations, particularly for the p53+/-cells. The somewhat inconsistent response of the p53+l-cells could in part be due to a conversion of a portion of these cells in culture to a p53-l-or -10 genotype; the rather unstable karyotype is supportive of this suggestion. Thus, no firm conclusions about the phenotype of p53 heterozygotes can be drawn from these studies.
Since the p53-l-cells had significantly elevated numbers of chromosomes compared to the p53+/+ or +/-cells, even at passages 4 or 5 used for the present studies, the chromosome aberration frequencies were calculated on a per chromosome basis. This provides a more reliable comparison of sensitivity. The data are shown for each experiment separately in Table I p53 status, DNA repair and chromatid aberration induction and with the two experiments combined in Figure 2 . There are highly significant differences between the total chromatid aberrations per chromosome for the p53-l-and +/-cells compared with the p53+/+ cells at 7.5 and 10 (ig/ml (P < 0.01), with much less of a difference at the two lower concentrations for the p53-l-cells and no difference for the +/-cells. Again, the response for the p53+/-cells is somewhat inconsistent, and no firm conclusion with regard to the phenotype of heterozygous p53 cells can be drawn. However, it would appear that some of the very large increase in aberration frequency at the higher concentrations is a consequence of p53 heterozygosity, possibly due to the sequestration of the wild-type p53 by the mutant form. It is important to note that there was an increase of chromatid deletions and interchanges in the p53-deficient cells at the higher bleomycin concentrations. The significance of this observation is discussed below.
There was a broad range in the distribution of aberrations per cell as shown in Table PL At all concentrations for the p5J-deficient cells, some cells showed extensive damage and yet quite a high proportion showed no or low levels of chromosome damage. The distributions were compared to a Poisson, and were found to be significantly different (P < 0.001) and overdispersed for the p55-deficient cells at 7.5 and 10 |ig/ml bleomycin. A proportion (~12%) of the p53+/+ cells contained fragmented metaphase chromosomes or highly clumped metaphase configurations. It is suggested that these might be representative of cells undergoing cell death, perhaps by an apoptotic pathway. Clearly, further study would be required to establish if this were indeed the case. However, it is notable that the chromosome fragmentation was largely restricted to the p53+/+ cells, and p53 has been shown to be involved in the apoptotic pathway following exposure to ionizing radiation (5) . In effect, these anomalous metaphases reduced the total frequency of aberrant cells in the p53+/+ analyzable cell population. However, it is not possible to determine how much of the chromosome damage was directly due to bleomycin, and how much might be due to the cell death process. Nevertheless, this loss of some aberrant cells would not have a significant impact upon the relative sensitivities of p53+/+ and p53-/-cells to chromatid aberration induction by bleomycin.
Another factor that would be very influential in causing differential sensitivities to aberration induction of G 2 in p53 wild-type and deficient cells is whether or not there is a difference in die rate at which cells reach mitosis after bleomycin treatment. A lowered mitotic index is considered to be indicative of a treatment-induced checkpoint. The mitotic indices as a function of bleomycin concentration for the tiiree cell lines are shown in Figure 3 . It can be seen that there is a reduction in the mitotic index tiiat is concentration dependent, but that it is similar in p53+/+, +/-and -/ -cell lines. This is interpreted as showing that the cells do have a treatmentinduced checkpoint but that this is independent of p53, and does not protect the p53-/-cells from producing a high frequency of chromatid aberration, bodi deletions and interchanges.
Checkpoint control in the cell cycle permits either repair of damaged DNA to take place prior to replication by maintaining the cells in Gj (32), or apoptosis of cells that are essentially irreparable (33, 34) . Although die mitotic, and by inference, Table II meiotic cycles proceed apparently normally in mice nullizygous for p53, a high incidence of tumor development is seen in p53 nullizygous mice compared with p53+l-or wild-type littermates (35, 36) . Embryonic fibroblasts from p53-l-mice show extensive karyotypic instability during in vitro culturing compared to p53+/+ fibroblasts (31, 37, 38) . This same tendency was also seen in the cell lines that we used, with elevated chromosome numbers in thep55-deficient cells at low passages. However, the majority of the cells remained diploid or tetraploid, with the most frequent deviations from this distribution occurring in 1hep53-/-cells (distribution patterns not shown). This observation supports the suggestion that murine p53 is a component of a mitotic spindle checkpoint in cells in culture, which helps ensure the maintenance of diploidy (39) .
The observed non-linear concentration-response curve for bleomycin-induced chromatid aberrations as well as the overdispersed frequency distribution is a common feature of bleomycin-induced aberrations (40, 41) . There was, however, an increase in the extent of overdispersion in the p53-lcells compared to p53+/+. This probably represents in part a non-random distribution of bleomycin dose or of induced DNA damage, with aberration frequency being a consequence of conversion of this damage into aberrations. This conversion is influenced by the p53 status of the cell. It is also feasible that the role of p53 in the repair of DNA damage becomes more significant as the total amount of DNA damage increases. There was also a significant difference in overdispersion for the p53+l-cells when compared to the p53+/+ cells. As mentioned above, this could be a result of the fact that a proportion of p53+l-cells are converted to p53-l-as a result of karyotypic instability during the four or five passages in culture or to the wild-type p53 being sequestered by the mutant form.
Gamma-irradiated, wild-type p53 cells exhibit transient arrest in both G] and G 2 , while only G 2 arrest is retained in cells with no or mutated p53 genes (5, 31, 36, 42, 43) , suggesting a control in addition to or as a substitution for p53 in G 2 . In addition, Paules et al. (23) reported that a rapid G 2 delay did not require p53 in early passage cells, with the requirement of p53 for a later delay being possible. Our data fit well with these observations, since we found a concentration-dependent decrease in mitotic index that was independent of p53 status of the cell. The increased frequencies of chromatid aberrations in bleomycin-treated G 2 p53-l-cells compared to p53+/+ cells must be the consequence of processes other than the abrogation of the G2/M checkpoint.
Our data differ somewhat from those of Bouffler et al. (44) who observed a y-ray-induced mitotic delay in p53+/+ spleen cells, but not in -/-cells. Their data on differences in chromosomal damage after irradiation are somewhat difficult to reconcile with this observation, since there was a variation in relative sensitivity to aberration induction among the cell lines with time after exposure (1-3 and 3-5 h), but the mitotic indices were presented as means for these same time periods, suggesting no variation in response. This and other experimental differences would need to be taken into account before a definitive comparison between the two studies can be made. Suffice it to say that there are differences in G 2 sensitivity of />53-proficient and p55-deficient cells to the induction of chromosome aberrations.
Chromosome aberrations arise in G| and G 2 phases from the failure to repair or from misrepair of DNA damage, particularly double-stranded breaks and modified bases, and in the S phase from errors of replication on a damaged DNA template. Bleomycin is a radiomimetic glycopeptide that induces double-strand DNA breaks, apurinic and apyrimidinic sites and 8-hydroxydeoxyguanine (40) . Repair of bleomycininduced DNA single-strand breaks seems to depend on poly-(ADP)ribose polymerase activation (44) , but the role of p53 has not been reported. In the present study the chromatid-type aberrations induced in G 2 are the result of failure to repair directly or indirectly induced double-strand breaks leading to deletions at metaphase, or incorrect repair leading to chromatid interchanges at metaphase. There was an increase in both types of aberrations in the absence of p53 or when p53 is heterozygous. This suggests that p53 is involved in the repair of some or all types of bleomycin-induced DNA damage, either through damage recognition as it is in G| (12, 24) or in recombination repair and/or excision repair directly (8) . The involvement of p53 in repair is supported by the fact that in its absence there is an increase in bleomycin-induced interchanges that require misrepair, since the rejoining process is, in fact, completed. At this time, it is not possible to determine the specific role of p53 in chromosome aberration formation.
It is important to extend the present observations to determine the specific role of p53 in the repair process, and the way in which the loss of p53 results in a reduction of repair efficiency. It is also necessary to determine if similar correlations between cellular p53 status and chromosome aberration sensitivity prevail in vivo.
